AbbVie Reports Full-Year and Fourth-Quarter 2021 Financial Results

/PRNewswire/ -- AbbVie (NYSE:ABBV) announced financial results for the fourth quarter and full year ended December 31, 2021. "We delivered another year of...

Related Keywords

,International Profit ,Abbvie Reports Full Year ,Full Year Diluted ,Adjusted Diluted ,Full Year Net Revenues ,Adjusted Net Revenues Were ,Year Global Net Revenues ,Immunology Portfolio Were ,Reported Basis ,Operational Basis ,Net Revenues Were ,Humira Net Revenues Were ,Biosimilar Competition ,Global Skyrizi Net Revenues Were ,Global Rinvoq Net Revenues Were ,Hematologic Oncology Portfolio Were ,Global Imbruvica Net Revenues Were ,International Profit Sharing ,Global Venclexta Net Revenues Were ,Neuroscience Portfolio Were ,Global Botox Therapeutic Net Revenues Were ,Vraylar Net Revenues Were ,Aesthetics Portfolio Were ,Global Botox Cosmetic Net Revenues Were ,Fourth Quarter Diluted ,Fourth Quarter Net Revenues ,Abbvie ,